Biotech has developed treatments and cures and also created high quality jobs, yet continued investment and innovation cannot be taken for granted. With the global economy in a tailspin, job losses are mounting and investments are decreasing. The new U.S. administration plans to reform health care and is pressed to drastically cut Medicare and
Medicaid expenditures. While the sector's innovation is still primarily centered in the United States, ambitious players have emerged in other parts of the world and are beginning to prominently influence business strategy. How will this impact the biotech industry? Join financial experts, biotech leaders and industry analysts for a dynamic discussion on creating innovation and bringing hope to patients in the current economic environment. How will these ventures be fi nanced and what must be managed to continue to build a strong biotech industry in the future.